NCT06127030 Brief Behavioral Teacher Training for Behavioral Difficulties
| NCT ID | NCT06127030 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Accare |
| Condition | Behavioral Difficulties |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-12-13 |
| Primary Completion | 2026-10-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-12-13 with a primary completion date of 2026-10-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this two-armed randomized controlled trial is to investigate the effectiveness of a new, individually tailored, brief behavioral training for teachers of children with behavioral difficulties at school. The main questions the study aims to answer are: * Does the brief teacher training reduce the severity of four daily rated target behaviors in specific classroom situations compared to practice as usual (PAU) on the short term? * Does the brief teacher training program reduce the severity of the same four daily rated target behaviors in other classroom situations, behavioral difficulties of the child at school and at home, and the impairment of the child in the school situation and reduce the number of behavioral difficulties of the child at school judged as troublesome by the teacher, and improve the teacher-student relationship quality, teachers' sense of efficacy, and teachers' behavior management strategies compared to practice as usual (PAU) on the short term? * Are short-term improvements maintained at 3 months follow-up? Teachers will be randomly assigned (simple randomization) to (a) three sessions of brief teacher training with PAU, or (b) PAU only. The brief teacher training provides teachers with individually tailored stimulus control and contingency management techniques to treat children's behavioral difficulties in two (bi)weekly training sessions of two hours and a third session of one hour in which the training will be evaluated and maintenance training will be provided. PAU may include any support or treatment as regularly provided by mental health care centers, schools, school collaborations and/or other organizations, except from pharmacological treatment for children's behavioral difficulties and/or behavioral teacher training/support. PAU can also imply that there is no support or treatment.
Eligibility Criteria
Inclusion criteria for the teachers will be: 1. The teacher works in regular elementary education, special elementary education or special education (in Dutch: cluster 4); 2. The teacher indicates that the child displays at least four behavioral difficulties in the classroom on a daily basis that the teacher wants to target in the training (using a list of target disruptive behaviors (Hornstra et al., 2021; Van den Hoofdakker et al., 2007)). Exclusion criterion for the teachers will be: 1. The teacher has received behavioral training or behavioral support aimed at remediating behavioral difficulties of the concerned child within the past year; 2. The teacher already participates in the study with another child. Exclusion criteria for the children will be: 1. The child has a diagnosis of autism spectrum disorder (as reported by parents, we will not perform any measures to assess autism spectrum disorder); 2. The child currently receives pharmacological treatment for behavioral difficulties (e.g., methylphenidate).
Contact & Investigator
Barbara van den Hoofdakker, Prof. dr.
PRINCIPAL INVESTIGATOR
Accare child study centre; University Medical Center Groningen
Frequently Asked Questions
Who can join the NCT06127030 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 13 Years, studying Behavioral Difficulties. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06127030 currently recruiting?
Yes, NCT06127030 is actively recruiting participants. Contact the research team at e.steenweg@accare.nl for enrollment information.
Where is the NCT06127030 trial being conducted?
This trial is being conducted at Groningen, Netherlands.
Who is sponsoring the NCT06127030 clinical trial?
NCT06127030 is sponsored by Accare. The principal investigator is Barbara van den Hoofdakker, Prof. dr. at Accare child study centre; University Medical Center Groningen. The trial plans to enroll 60 participants.